Bullish Stocks Commentary: Camtek Ltd, Lions Gate Entertainment, ImmunoCellular Therapeutics, Pandora Media, Amarin Corporation

NEW YORK, November 26, 2013 /PRNewswire/ --

Market Buzz Report, provides free trend analysis on penny stocks, issues latest stock news for Camtek LTD.(NASDAQ:CAMT), Lions Gate Entertainment Corp. (NYSE:LGF), ImmunoCellular Therapeutics Ltd(NYSE:IMUC), Pandora Media Inc (NYSE:P), Amarin Corporation plc (NASDAQ:AMRN).

Camtek LTD.(NASDAQ:CAMT) surges 33.6% pre-market on heavy volume, adding to Friday's 39.5% gain.The most probable cause of the move? A bull argument by SA contributor super-trades which claims that the stock should be considered a 3D printing play given the company's planned 2014 roll out of a commercial 3D printer that manufactures Printed Circuit Boards. The author calls it "the world's first."

Free Urgent Insider Catalyst Report For CAMT Available Here:  http://marketbuzzreport.com/index.php?code=CAMT  (Or Copy and paste the URL into your browser)

Lions Gate Entertainment Corp. (USA)(NYSE:LGF) is down sharply on volume 4X normal trading activity as massive box office success for the Hunger Games: Catching Fire wasn't enough to exceed the even larger expectations that were apparently baked into LGF's stock price.Analysts are out with some pithy analysis on the global potential of HG and more box office breakdowns which don't seem to be nudging sentiment.10 of 12 investment firms covering the movie studio concern have a solid Buy rating (no Sells) on LGF which they backed right through the HG premiere.B Riley says it's "very comfortable" with a gigantic $900M global box office estimate for the movie, but until momentum straightens out the knife could still be falling.

Free Urgent Insider Catalyst Report For LGF Available Here:  http://marketbuzzreport.com/index.php?code=LGF  (Or Copy and paste the URL into your browser)

ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) rallies hard after Cedars-Sinai provides an update on a study of ICT-107 in glioblastoma multiforme.Eight of sixteen patients survived for longer than five years post-diagnosis.Six patients were progression free at five years.Four patients are still free of disease with "good quality of life at lengths from 65.1-82.7 months following diagnosis." (PR)As for the Street's take: Roth adds IMUC to its Focus List. Price target is $9.

Free Urgent Insider Catalyst Report For IMUC Available Here:  http://marketbuzzreport.com/index.php?code=IMUC  (Or Copy and paste the URL into your browser)

Pandora Media Inc (NYSE:P) shares fell 4.89% to $27.82. The company on Nov. 22 announced financial results for the third quarter of fiscal year 2014 ended on October 31, 2013. For the third quarter of fiscal 2014, GAAP total revenue was $180.4 million, a 50% year‐over‐year increase. For the third quarter of fiscal 2014, GAAP basic and diluted EPS were ($0.01). Non‐GAAP diluted EPS was $0.06. For the third quarter of fiscal 2014, the Company ended with $447.8 million in cash, cash equivalents and short‐term investments, compared with $68.9 million at the end of the prior quarter.

Free Urgent Insider Catalyst Report For P Available Here:  http://marketbuzzreport.com/index.php?code=P  (Or Copy and paste the URL into your browser)

Shares of Amarin Corporation plc (ADR)(NASDAQ:AMRN) are bouncing back in past few minutes and soars 8% to $1.91 after slumping 12% in Friday's session following the Food and Drug Administration refused to reconsider a recent decision that casts doubt on the future of the company's lead product. The Irish drug maker said in a regulatory filing that the FDA refused to consider the company's appeal of an Oct. 29 decision to terminate an agreement that would have expanded approval of Amarin's drug Vascepa if the company showed it lowered triglycerides, a type of fat in the bloodstream. The FDA said that it no longer considers a change in triglyceride levels enough to establish the effectiveness of a drug that aims to reduce the risk of cardiovascular problems like heart attacks in certain patients. The agency also rejected Amarin's request for a meeting with a high-level official to discuss the appeal.

Free Urgent Insider Catalyst Report For AMRN Available Here:  http://marketbuzzreport.com/index.php?code=AMRN  (Or Copy and paste the URL into your browser)

USMarketBuzz.com is an investment community that Focuses on MicroCap Securities. USMarketBuzz.com is an  authorative authentic Google News Site and  Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/   for more details. Get an edge on the market with our Premium News Alerts   that are FREE for a limited time at http://www.USMarketBuzz.com/. Follow us on Facebook:  https://www.facebook.com/usmarket.buzz Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126.  (SMS alerts are free, however data rates may apply, check your wireless plan for details.)

DISCLAIMER:  FNNewswire (FNNW) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNNW is NOT affiliated in any manner with MarketBuzz Reports, USMarketBuzz.com or any company mentioned herein.  The commentary, views and opinions expressed in this release by MarketBuzz Reports and USMarketBuzz.com are solely those of the MarketBuzz Reports & USMarketBuzz.com and are not shared by and do not reflect in any manner the views or opinions of FNNW. The companies that are discussed herein may or may not have approved the statements made in this release.  FNNW is not liable for any investment decisions by its readers or subscribers FNNW and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNNW was not compensated by any public company mentioned herein to disseminate this press release.

FNNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.  

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNNW undertakes no obligation to update such statements.

FNNW Contact Information:
Company:  FN Newswire
Contact email:   [email protected] 
U.S. Phone: +1(954)345-0611

SOURCE FN Media Group, LLC